4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0002083206-26-000002
Chief Financial Officer acquired 44,665 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tamayo Louis Edward Chief Financial Officer | 2026-02-04 | Grant or award | +44,665 | 89,665 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Tamayo Louis Edward Chief Financial Officer | 2026-02-04 | Grant or award · Stock Option (right to buy) | +226,665 | 226,665 | D: show line 2 in the form |
Loading xslF345X05/form4-02062026_050201.xml…